PT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder

Journal of Urology

Volumn 184, Issue 2, 2010, Pages 470-474

  Tilki, Derya ^a   Svatek, Robert S ^b   Karakiewicz, Pierre I ^d   Novara, Giacomo ^g   Seitz, Michael ^a   Sonpavde, Guru ^c   Gupta, Amit ^b   Kassouf, Wassim ^e   Fradet, Yves ^f   Ficarra, Vincenzo ^g   Skinner, Eila ^h   Lotan, Yair ^b   Sagalowsky, Arthur I ^b   Stief, Christian G ^a   Reich, Oliver ^a   Shariat, Shahrokh F ⁱ  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^f UNIVERSITÉ LAVAL   (Canada)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

carcinoma; mortality; neoplasm staging; urinary bladder; urothelium

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL ASSESSMENT; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 77955466728     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.04.007     Document Type: Article

References (14)

1. I.D. Fleming, J.S. Cooper, and D.E. Hensen AJCC Cancer Staging Manual 5th ed. 1997 Lippincott-Raven Philadelphia 241
2. M.L. Quek, J.P. Stein, and P.E. Clark Natural history of surgically treated bladder carcinoma with extravesical tumor extension Cancer 98 2003 955
3. M.L. Quek, J.P. Stein, and P.E. Clark Microscopic and gross extravesical extension in pathological staging of bladder cancer J Urol 171 2004 640
4. G. Dalbagni, E. Genega, and M. Hashibe Cystectomy for bladder cancer: a contemporary series J Urol 165 2001 1111
5. K.J. Boudreaux Jr, S.S. Chang, and W.T. Lowrance Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes Cancer 115 2009 770
6. P.J. Bastian, G.C. Hutterer, and S.F. Shariat Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival BJU Int 101 2008 450
7. J.P. Stein, G. Lieskovsky, and R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666
8. F. Pagano, P. Bassi, and T.P. Galetti Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification J Urol 145 1991 45
9. S. Madersbacher, W. Hochreiter, and F. Burkhard Radical cystectomy for bladder cancer todaya homogeneous series without neoadjuvant therapy J Clin Oncol 21 2003 690
10. M.A. Ghoneim, M. Abdel-Latif, and M. el-Mekresh Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later J Urol 180 2008 121
11. R.J. Yu, J.P. Stein, and J. Cai Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy J Urol 176 2006 493
12. M. Stockle, W. Meyenburg, and S. Wellek Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience J Urol 153 1995 47
13. F. Freiha, J. Reese, and F.M. Torti A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer J Urol 155 1996 495
14. D.G. Skinner, J.R. Daniels, and C.A. Russell The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J Urol 145 1991 459